Gabapentin Dosing: Increasing from 400mg Capsules to 600mg TID
Order gabapentin 600mg three times daily by prescribing one and a half 400mg capsules per dose (600mg total per dose), taken three times daily, for a total daily dose of 1800mg.
Practical Prescription Details
Since the patient currently has 400mg capsules available, the most straightforward approach is:
- Dispense: Gabapentin 400mg capsules
- Directions: Take one and a half (1.5) capsules by mouth three times daily
- Total daily dose: 1800mg (600mg × 3 doses)
Alternative Ordering Options
If splitting capsules is problematic or undesirable:
- Switch to 600mg tablets: Prescribe gabapentin 600mg tablets, take one tablet three times daily 11
- Use combination dosing: Prescribe both 400mg and 200mg capsules, instructing the patient to take one 400mg + one 200mg capsule three times daily
Titration Considerations
The FDA-approved dosing for postherpetic neuralgia demonstrates that gabapentin can be rapidly titrated to 600mg TID 11:
- Day 1: 300mg once
- Day 2: 300mg twice daily (600mg total)
- Day 3: 300mg three times daily (900mg total)
- Subsequently titrate to 600mg three times daily (1800mg total)
Guidelines support increasing by 100-300mg every 1-7 days as tolerated 222. Since your patient is already on 400mg capsules (presumably at a lower frequency), the increase to 600mg TID represents appropriate dose escalation within established parameters.
Important Clinical Caveats
Renal function must be assessed before this dose increase. Gabapentin requires dose reduction in renal impairment 11:
- CrCl ≥60 mL/min: Full dose of 600mg TID is appropriate
- CrCl 30-59 mL/min: Maximum 700mg BID
- CrCl 15-29 mL/min: Maximum 700mg once daily
- CrCl <15 mL/min: Maximum 300mg once daily
Maximum time between doses should not exceed 12 hours due to gabapentin's nonlinear pharmacokinetics from saturable absorption 11.
Common dose-dependent side effects include dizziness and sedation, which can be minimized through gradual titration 222. If the patient experiences significant adverse effects at 600mg TID, consider a slower titration schedule.
Efficacy Context
The 1800mg daily dose (600mg TID) represents an evidence-based therapeutic target. Clinical trials demonstrate efficacy at 1800-3600mg daily, with 1800mg/day being the minimum effective dose for most neuropathic pain conditions 113. Research indicates that treatment should start at 900mg/day and titrate to at least 1800mg/day for optimal efficacy 3.
Higher doses up to 3600mg daily may provide additional benefit in some patients, though this requires further titration over 3-8 weeks 222.